Novavax CEO contends COVID vaccine is 'more stable' than alternatives, could reduce 'all disease'
Novavax President and CEO Stanley Erck asserted the biotech's COVID-19 vaccine endorsed by the CDC for adults is "quite a bit different" than its alternatives, telling "Cavuto: Coast to Coast" Thursday it is "more stable" and could possibly reduce "all disease."
STANLEY ERCK: It’s quite a bit different, we have a vaccine that like the others have shown great efficacy and a great safety database. Ours is a bit more stable than the others, so you can distribute the vaccine and use it at refrigerated temperatures instead of having to take it at...